ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: A patient-level meta-analysis of randomized trials
Salvatore Cassese, Alfredo E. Rodríguez(Sanatorio Otamendi y Miroli), Mara Sansa(Azienda Ospedaliera Ospedale Maggiore), Siniša Stojković(University of Belgrade), Flavio Ribichini(Azienda Ospedaliera Universitaria Integrata Verona), Corrado Vassanelli(University of Verona), David Antoniucci(Azienda Ospedaliero-Universitaria Careggi), Giuseppe De Luca(University of Messina), Goran Stanković(University of Belgrade), Igino Proietti, Francesco Versaci(Ospedale Santa Maria Goretti), Patrick W. Serruys(Erasmus MC), C Cernigliaro(IRCCS Humanitas Research Hospital), Adnan Kastrati(Deutsches Herzzentrum München), Carlos Fernández‐Pereira(Sanatorio Otamendi y Miroli), Fabrizio Tomai(European Hospital)
Cited by 21
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k